Results 91 to 100 of about 35,159 (258)

Unravelling dialysis‐related dysglycaemia: Longitudinal insights from continuous glucose monitoring

Diabetic Medicine, EarlyView.
Abstract Aim To characterise CGM‐derived glycaemic trajectories over 12months in people receiving maintenance haemodialysis, with a particular focus on hypoglycaemia burden and composite glycaemic risk. Methods We conducted a longitudinal observational study. CGM data were collected at baseline, 6 and 12 months.
Hellena Hailu Habte‐Asres, Ayodele Agbabiaka, Roha Rehan, David C. Wheeler, Miranda Rosenthal   +4 more
wiley   +1 more source

Control of a wind energy conversion system based on brushless doubly fed induction generator

Revue des Énergies Renouvelables, 2014
This paper discusses the control a new topology of a brushless doubly-fed induction generator (BDFIG) using back-to-back PWM converters. The goal of BDFIG control is to achieve a similar dynamic performance to the doubly fed induction generator (DFIG ...
Z. Tir, R. Abdessemed
doaj  

D‐ACTnow—A diabetes‐specific group‐based psychological intervention for young adults with type 1 diabetes and elevated diabetes distress: Results from a single‐arm pilot study

Diabetic Medicine, EarlyView.
Abstract Aim To test the feasibility of a group‐based psychological intervention for young adults with type 1‐diabetes and elevated diabetes distress. Methods Young adults (18–30 years), screened for diabetes distress using the Type 1 Diabetes Distress Scale (T1‐DDS), participated in six group sessions led by a psychologist and a diabetes nurse.
Tanja Schmidt, Emilie Just‐Østergaard, Julie Drotner Mouritsen, Grete Skøtt Pedersen, François Pouwer, Claus Bogh Juhl   +5 more
wiley   +1 more source

Clustering of technological attitudes and reasons for device (non‐)uptake among Dutch people with type 1 diabetes, family members and health professionals

Diabetic Medicine, EarlyView.
Abstract Background Pump and sensor technology contributes to glucose management and quality of life for people with type 1 diabetes (PWD). However, not everyone uses these technologies. This commonly relates to technological attitudes, experiences and expectations. Also, parents and partners (P/P) and healthcare providers (HCPs) may impactful decision‐
M. Horsselenberg, J. B. Prins, M. Boenink, H. J. Aanstoot, G. Nefs   +4 more
wiley   +1 more source

Tir...Mbo!

, 2020
This music score was submitted for the Kaleidoscope 2020 Call for Scores, an open access collaboration with the UCLA Music Library.
openaire   +1 more source

Glycaemic penalty index as an independent predictor of healthcare‐associated infection in surgical inpatients: A nested cohort study from the STOIC‐D surgery trial

Diabetic Medicine, EarlyView.
Higher glycaemic burden, measured by the Glycaemic Penalty Index (GPI), was independently associated with increased risk of healthcare‐associated infection in surgical inpatients. GPI provides a single, clinically interpretable summary of both hyperglycaemia and hypoglycaemia. Abstract Aims To evaluate the utility of the Glycemic Penalty Index (GPI), a
Gabrielle Blomson, Rahul D. Barmanray, Mervyn Kyi, Peter G. Colman, Leon J. Worth, Minh V. Le, Emily Sun, Spiros Fourlanos   +7 more
wiley   +1 more source

Learning Unsupervised Cross-Domain Model for TIR Target Tracking

Mathematics
The limited availability of thermal infrared (TIR) training samples leads to suboptimal target representation by convolutional feature extraction networks, which adversely impacts the accuracy of TIR target tracking methods.
Xiu Shu, Feng Huang, Zhaobing Qiu, Xinming Zhang, Di Yuan   +4 more
doaj   +1 more source

The impact of frailty on glycaemic control in older adults with type 1 diabetes: An observational study

Diabetic Medicine, EarlyView.
Abstract Aims The type 1 diabetes population is ageing. Frailty is the age‐related physiological decline that occurs across organ systems, increasing the body's vulnerability to stressors. Current consensus‐based guidelines, derived from evidence in type 2 diabetes, prioritise hypoglycaemia avoidance, which increases falls, hospitalisation and ...
Jonathan A. Golding, Scarlett O. Long, Suzy V. Hope, Juliet E. Wright, Ali J. Chakera, Tom J. Levett   +5 more
wiley   +1 more source

A Phase 2 Trial of Frexalimab, a CD40L Antagonist, in Adolescents and Adults With Recent‐Onset Type 1 Diabetes (FABULINUS): Rationale and Study Design

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Introduction Type 1 diabetes (T1D) is a chronic autoimmune disease, characterised by progressive destruction of the insulin‐producing pancreatic β‐cells. Preserving remaining β‐cells at the time of diagnosis may improve long‐term outcomes. Frexalimab is a humanised monoclonal antibody specific for CD40L undergoing evaluation for treatment of ...
Andriy Cherkas, Baerbel Rotthaeuser, Niels Porksen, Pascale Labard, My‐Liên Nguyên‐Pascal, Mathieu Coudert, Baptiste Berthou, Marie Baccara‐Dinet, Gabor Boka, Mark Peakman, Felix Reschke, Michael J. Haller   +11 more
wiley   +1 more source

Simplified Switching to Once‐Weekly Insulin Icodec Without an Initial One‐Time Additional Dose Versus Once‐Daily Insulin Glargine U100 in Basal Insulin‐Treated Type 2 Diabetes (ONWARDS 10): A Randomised Controlled Trial

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims ONWARDS 10 assessed switching from daily basal insulins to once‐weekly insulin icodec without a one‐time additional dose at first injection. Materials and Methods In this treat‐to‐target, open‐label, 26‐week, phase 3b trial, adults with basal‐insulin‐treated type 2 diabetes (T2D) with glycated haemoglobin [HbA1c] 7.0%–10.0% were ...
Julio Rosenstock, Chantal Mathieu, Joshua Buron Feinberg, Priyanka Rao, Cathrine Scavenius, Alice Y. Y. Cheng   +5 more
wiley   +1 more source